Bausch Health Cos Total Non-Operating Income/Expense 2010-2024 | BHC

Bausch Health Cos total non-operating income/expense from 2010 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
Bausch Health Cos Annual Total Non-Operating Income/Expense
(Millions of US $)
2023 $-1,353
2022 $-583
2021 $-1,474
2020 $-1,610
2019 $-1,634
2018 $-1,770
2017 $-1,843
2016 $-1,869
2015 $-1,682
2014 $-947
2013 $-905
2012 $-474
2011 $-318
2010 $-126
2009 $-6
Bausch Health Cos Quarterly Total Non-Operating Income/Expense
(Millions of US $)
2024-09-30 $-339
2024-06-30 $-341
2024-03-31 $-350
2023-12-31 $-369
2023-09-30 $-340
2023-06-30 $-333
2023-03-31 $-311
2022-12-31 $-113
2022-09-30 $195
2022-06-30 $-290
2022-03-31 $-375
2021-12-31 $-346
2021-09-30 $-358
2021-06-30 $-400
2021-03-31 $-370
2020-12-31 $-389
2020-09-30 $-385
2020-06-30 $-410
2020-03-31 $-426
2019-12-31 $-394
2019-09-30 $-395
2019-06-30 $-436
2019-03-31 $-409
2018-12-31 $-451
2018-09-30 $-417
2018-06-30 $-489
2018-03-31 $-413
2017-12-31 $-482
2017-09-30 $-438
2017-06-30 $-417
2017-03-31 $-506
2016-12-31 $-510
2016-09-30 $-469
2016-06-30 $-458
2016-03-31 $-432
2015-12-31 $-434
2015-09-30 $-454
2015-06-30 $-406
2015-03-31 $-388
2014-12-31 $-54
2014-09-30 $-307
2014-06-30 $-234
2014-03-31 $-352
2013-12-31 $-302
2013-09-30 $-250
2013-06-30 $-182
2013-03-31 $-172
2012-12-31 $-177
2012-09-30 $-119
2012-06-30 $-104
2012-03-31 $-75
2011-12-31 $-71
2011-09-30 $-100
2011-06-30 $-75
2011-03-31 $-72
2010-12-31 $-85
2010-09-30 $-22
2010-06-30 $-9
2010-03-31 $-10
2009-12-31 $-11
2009-09-30 $-10
2009-06-30 $17
2009-03-31 $-2
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.439B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.679B 6.46
Dr Reddy's Laboratories (RDY) India $12.521B 23.96
BridgeBio Pharma (BBIO) United States $4.911B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.335B 14.04
Supernus Pharmaceuticals (SUPN) United States $2.022B 27.53
Taysha Gene Therapies (TSHA) United States $0.334B 54.33
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.104B 0.00
Sol-Gel Technologies (SLGL) Israel $0.015B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00